StockData
FOXO Technologies Inc. logo

FOXO Technologies Inc. (FOXO) stock

FOXOOTCServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as FOXOW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.10−0.01 (-9.09%)

Close on Oct 19, 2026Market cap –P/E –Yield –

FOXO Technologies Inc. grew revenue 44.0% to $17.86M over the twelve months to Jun 30, 2026. Free cash flow was -$3.93M.

Revenue
$17.86M
+44.0% vs. a year earlier
Operating income
-$877.76K
TTM Q2 2026
Free cash flow
-$3.93M
FY2025

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Fundamentals

Revenue
$17.86M
Net income
-$4.60M
Free cash flow
-$3.93M

Trading

Previous close
$0.11
Open
$0.10
Day's range
$0.10 – $0.10
Volume
2,483
Average volume (20 days)
5,670

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.

PeriodFOXOS&P 500DifferenceFOXO per yearS&P 500 per year
1 month-24.2%+0.6%−24.8 pts
3 months+58.7%+3.4%+55.4 pts
Year to date-66.7%+13.3%−79.9 pts
1 year-97.0%+16.6%−113.6 pts
3 years-100.0%+86.4%−186.4 pts-98.5%+23.1%

Six years at a glance

Fiscal years 2020 to 2025 and trailing twelve months, USD

Revenue

$17.86M+44.0% YoY

Gross profit

–

Operating income

-$877.76K

Net income

-$4.60M

Free cash flow

–
Reported periodTrailing twelve months

Press releases

Releases FOXO Technologies filed with the SEC as exhibits to Form 8-K or 6-K

  1. TECHNOLOGIES INC. ANNOUNCES AGREEMENTS TO ACQUIRE PREFERRED STOCK CARRYING MAJORITY VOTING POWER IN LUDWIG ENTERPRISES, INC.
    Update
  2. TECHNOLOGIES INC.’S SUBSIDIARY VECTOR BIOSOURCE, INC. ENTERS INTO DEFINITIVE AGREEMENT TO ACQUIRE FOUR BLOOD COLLECTION CENTERS
    Update
  3. TECHNOLOGIES INC. CEO SEAMUS LAGAN PROVIDES MID-YEAR UPDATE TO SHAREHOLDERS
    Update
  4. TECHNOLOGIES INC. ANNOUNCES COMPLETION OF REVERSE STOCK SPLIT
    Update
  5. TECHNOLOGIES, INC., FORMS STRATEGIC PARTNERSHIP WITH LONGEVITYFP TECHNOLOGIES, LLC. TO COMMERCIALIZE FOXO’S EPIGENETICS TECHNOLOGY
    Update
  6. Technologies Inc. Subsidiary, Big South Fork Medical Center, Expands Clinical Capabilities
    Update
All press releases and earnings

About FOXO Technologies

Services-Commercial Physical & Biological Research

FOXO Technologies Inc. engages in activities spanning the healthcare, biotechnology, and behavioral health sectors through its subsidiaries and business agreements. The company’s operations involve behavioral health services, medical equipment, and software development, in addition to epigenetic applications and methylation data pipelines. Its commercial activities include structured service arrangements and acquisitions involving partners such as Myrtle Recovery Centers, Rennova Community Health, and Vector Acquisition to serve individuals requiring behavioral health and related medical care.

Company profile, executives and history

FOXO Technologies stock: common questions

What is FOXO Technologies's stock price?

FOXO closed at $0.10 on Oct 19, 2026, down 9.09% on the day.

How much revenue does FOXO Technologies make?

FOXO Technologies reported revenue of $17.86M for the twelve months to Jun 30, 2026, up 44.0% from a year earlier.

Does FOXO Technologies pay a dividend?

No. FOXO Technologies has not paid a cash dividend over the last twelve months.

How has FOXO stock performed over the past year?

Including dividends, FOXO returned -97.0% over the past year, against +16.6% for the S&P 500.

Who are FOXO Technologies's competitors?

Companies most similar to FOXO Technologies by business, industry and size include MXCT, OABI, NRC, ONMD, BIAF.

See a number that looks wrong?